{"data":[{"accessionNo":"0001950047-26-008424","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":30000,"aggregateMarketValue":2489400,"unitsOutstanding":195487474,"approxSaleDate":"2026-08-19","exchange":"NASDAQ","filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-008337","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"NEIL KUMAR","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":34980,"aggregateMarketValue":2794552.2,"unitsOutstanding":195487474,"approxSaleDate":"2026-08-18","exchange":"NASDAQ","filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-008246","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"RANDAL SCOTT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":21501,"aggregateMarketValue":1717069.86,"unitsOutstanding":195487474,"approxSaleDate":"2026-08-17","exchange":"NASDAQ","filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006979","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"JENNIFER COOK","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":148589,"aggregateMarketValue":13156008,"unitsOutstanding":195861242,"approxSaleDate":"2026-07-09","exchange":"NASDAQ","filedAt":"2026-07-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006976","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"ANDREA ELLIS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":17167,"aggregateMarketValue":1442028,"unitsOutstanding":195861242,"approxSaleDate":"2026-07-09","exchange":"NASDAQ","filedAt":"2026-07-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006457","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"RANDAL SCOTT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2196,"aggregateMarketValue":150711.48,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-24","exchange":"NASDAQ","filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006442","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"JENNIFER COOK","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":37167,"aggregateMarketValue":2601690,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-24","exchange":"NASDAQ","filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006434","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"JENNIFER COOK","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2196,"aggregateMarketValue":150579.72,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-23","exchange":"NASDAQ","filedAt":"2026-06-23","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006404","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"HANNAH A VALANTINE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2196,"aggregateMarketValue":150579.72,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-23","exchange":"NASDAQ","filedAt":"2026-06-23","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006349","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"HANNAH A VALANTINE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2808,"aggregateMarketValue":190944,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-22","exchange":"NASDAQ","filedAt":"2026-06-22","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-006155","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"JENNIFER COOK","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":90240,"aggregateMarketValue":6012159.04,"unitsOutstanding":195861242,"approxSaleDate":"2026-06-15","exchange":"NASDAQ","filedAt":"2026-06-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-004909","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"NEIL KUMAR","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":26103,"aggregateMarketValue":1780746.66,"unitsOutstanding":195861242,"approxSaleDate":"2026-05-21","exchange":"NASDAQ","filedAt":"2026-05-21","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-004675","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"THOMAS TRIMARCHI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":13651,"aggregateMarketValue":888419.37,"unitsOutstanding":195861242,"approxSaleDate":"2026-05-18","exchange":"NASDAQ","filedAt":"2026-05-18","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-003358","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA INC","ticker":"BBIO","personName":"KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":120000,"aggregateMarketValue":8896800,"unitsOutstanding":193862871,"approxSaleDate":"2026-04-09","exchange":"NASDAQ","filedAt":"2026-04-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-002594","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA FAMILY IRREVOCABLE TRUST","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":140000,"aggregateMarketValue":9517200,"unitsOutstanding":193862871,"approxSaleDate":"2026-03-13","exchange":"NASDAQ","filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-002400","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"HANNAH A VALANTINE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8671,"aggregateMarketValue":624312,"unitsOutstanding":193862871,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-002147","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"ANDREA ELLIS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":64921,"aggregateMarketValue":4211300.16,"unitsOutstanding":193862871,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-001893","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"HANNAH A VALANTINE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25484,"aggregateMarketValue":1717779.6,"unitsOutstanding":193862871,"approxSaleDate":"2026-02-27","exchange":"NASDAQ","filedAt":"2026-02-27","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-001512","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"NEIL KUMAR","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":28053,"aggregateMarketValue":2073958.29,"unitsOutstanding":192708813,"approxSaleDate":"2026-02-19","exchange":"NASDAQ","filedAt":"2026-02-19","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-001375","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"RANDAL SCOTT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":1505000,"unitsOutstanding":192708813,"approxSaleDate":"2026-02-17","exchange":"NASDAQ","filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-001308","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"THOMAS TRIMARCHI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":13600,"aggregateMarketValue":1016147.12,"unitsOutstanding":192708813,"approxSaleDate":"2026-02-17","exchange":"NASDAQ","filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-000276","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":120000,"aggregateMarketValue":8912400,"unitsOutstanding":192708813,"approxSaleDate":"2026-01-08","exchange":"NASDAQ","filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-26-000275","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA FAMILY IRREVOCABLE TRUST","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":100000,"aggregateMarketValue":7427000,"unitsOutstanding":192708813,"approxSaleDate":"2026-01-08","exchange":"NASDAQ","filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-010321","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"NEIL KUMAR","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":30011,"aggregateMarketValue":2255326.65,"unitsOutstanding":192708813,"approxSaleDate":"2025-12-15","exchange":"NASDAQ","filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-009146","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"NEIL KUMAR","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":26156,"aggregateMarketValue":1714264.24,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-20","exchange":"NASDAQ","filedAt":"2025-11-20","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-009007","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"ANDREW W LO","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":55000,"aggregateMarketValue":3613065.5,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-18","exchange":"NASDAQ","filedAt":"2025-11-18","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-008990","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"ANDREW W LO","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":40599,"aggregateMarketValue":2706589.17,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-008947","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"RANDAL SCOTT","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":663900,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-008929","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"THOMAS TRIMARCHI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16934,"aggregateMarketValue":1125403.16,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-008752","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"Hannah A Valantine","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25484,"aggregateMarketValue":1683727.88,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-12","exchange":"NASDAQ","filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-008535","issuerCik":"0001743881","issuerName":"BRIDGEBIO PHARMA, INC.","ticker":"BBIO","personName":"RONALD J DANIELS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":61031,"aggregateMarketValue":3888999.07,"unitsOutstanding":192708813,"approxSaleDate":"2025-11-06","exchange":"NASDAQ","filedAt":"2025-11-06","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001628280-25-047224","issuerCik":"0001743881","issuerName":"BridgeBio Pharma","ticker":"BBIO","personName":"Frank McCormick","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":198359,"aggregateMarketValue":13206531.76,"unitsOutstanding":191168504,"approxSaleDate":"2025-10-29","exchange":"Nasdaq","filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001628280-25-046423","issuerCik":"0001743881","issuerName":"BridgeBio Pharma","ticker":"BBIO","personName":"Frank McCormick","relationship":"Director","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":1641,"aggregateMarketValue":106665,"unitsOutstanding":191168504,"approxSaleDate":"2025-10-27","exchange":"Nasdaq","filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-007840","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA FAMILY IRREVOCABLE TRUST","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":120000,"aggregateMarketValue":6506400,"unitsOutstanding":191168504,"approxSaleDate":"2025-10-08","exchange":"NASDAQ","filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},{"accessionNo":"0001950047-25-007839","issuerCik":"0001743881","issuerName":"BridgeBio Pharma, Inc.","ticker":"BBIO","personName":"KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":120000,"aggregateMarketValue":6506400,"unitsOutstanding":191168504,"approxSaleDate":"2025-10-08","exchange":"NASDAQ","filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"}],"updatedAt":"2026-10-30T12:39:20.947Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bbio","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}